NMPA Approval

Darbepoetin alfa Injection

Approval Number

S20200014

Registration Date

June 17, 2020

Drug Information

Generic Name

达依泊汀α注射液

Trade Name

耐斯宝

Dosage Form

注射剂

Strength

40μg/0.5mL

Drug Type

生物制品

Registration Date

June 17, 2020

Expiry Date

June 16, 2025

Company Address

1-9-2 Otemachi, Chiyoda-ku, Tokyo, Japan

Company Name

terumo corporation, kofu factory

Company Address

1727-1 Tsuijiarai, Showa-cho, Nakakoma-gun, Yamanashi, 409-3853, Japan

Empowering clinical research with data-driven insights and AI-powered tools.